<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Urology Product Guide &#187; Labor and Welfare</title>
	<atom:link href="http://www.urologyproductguide.com/blog/tag/labor-and-welfare/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.urologyproductguide.com/blog</link>
	<description>A comprehensive guide to urology products for medical professionals</description>
	<lastBuildDate>Fri, 23 Jul 2010 08:07:11 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.2</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>First Non-Invasive Technology For Treatment Of Uterine Fibroids Awarded MHLW Approval In Japan</title>
		<link>http://www.urologyproductguide.com/blog/2010/01/22/first-non-invasive-technology-for-treatment-of-uterine-fibroids-awarded-mhlw-approval-in-japan/</link>
		<comments>http://www.urologyproductguide.com/blog/2010/01/22/first-non-invasive-technology-for-treatment-of-uterine-fibroids-awarded-mhlw-approval-in-japan/#comments</comments>
		<pubDate>Fri, 22 Jan 2010 05:37:10 +0000</pubDate>
		<dc:creator>Seth Sullivan</dc:creator>
				<category><![CDATA[Female Urology]]></category>
		<category><![CDATA[ExAblate(R)]]></category>
		<category><![CDATA[InSightec Ltd]]></category>
		<category><![CDATA[Labor and Welfare]]></category>
		<category><![CDATA[Ministry of Health]]></category>
		<category><![CDATA[MR-guided Focused Ultrasound]]></category>
		<category><![CDATA[uterine fibroids]]></category>

		<guid isPermaLink="false">http://www.urologyproductguide.com/blog/?p=172</guid>
		<description><![CDATA[InSightec Ltd. announced that Japan&#8217;s Ministry of Health, Labor and Welfare (MHLW) has approved the company&#8217;s ExAblate(R) MR-guided Focused Ultrasound (MRgFUS) system for the treatment of women with uterine fibroids. ExAblate is currently the only noninvasive treatment for uterine fibroids approved for use in Japan. Approximately 25% Japanese women will develop symptomatic uterine fibroids, primarily [...]]]></description>
			<content:encoded><![CDATA[<p><a href="http://www.urologyproductguide.com/blog/wp-content/uploads/2010/01/InSightec-Ltd.png"><img class="alignleft size-full wp-image-173" src="http://www.urologyproductguide.com/blog/wp-content/uploads/2010/01/InSightec-Ltd.png" border="0" alt="InSightec Ltd" width="200" height="48" /></a>InSightec Ltd. announced that Japan&#8217;s Ministry of Health, Labor and Welfare (MHLW) has approved the company&#8217;s ExAblate(R) MR-guided Focused Ultrasound (MRgFUS) system for the treatment of women with uterine fibroids. ExAblate is currently the only noninvasive treatment for uterine fibroids approved for use in Japan. Approximately 25% Japanese women will develop symptomatic uterine fibroids, primarily during childbearing years. These benign tumors can significantly impair functionality and degrade quality of life resulting in significant work absences.</p>
<p>For the full story, <a href="http://www.medicalnewstoday.com/articles/175941.php" target="_blank">Click Here</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.urologyproductguide.com/blog/2010/01/22/first-non-invasive-technology-for-treatment-of-uterine-fibroids-awarded-mhlw-approval-in-japan/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
